H.R. 5969: Linking Abortion-drug Batches for Enforcement and Liability Act

This bill, titled the "Linking Abortion-drug Batches for Enforcement and Liability Act" or the "LABEL Act," proposes amendments to existing regulations concerning abortion-inducing drugs under the Federal Food, Drug, and Cosmetic Act. The key components of the bill include:

Labeling Requirements

The bill mandates that all abortion-inducing drugs must carry specific labeling that includes:

• The name and address of the dispenser (the pharmacy or facility providing the drug).
• The name of the prescriber (the healthcare professional who prescribed the drug).

If an abortion-inducing drug does not have this labeling, it would be considered "misbranded" under the law.

State Regulations

Additionally, the bill stipulates that no state or local government can implement or enforce labeling requirements for abortion-inducing drugs that are less stringent than those established by this federal legislation.

Definition of Abortion-inducing Drug

The bill defines abortion-inducing drugs as those intended to terminate the pregnancy or kill the unborn child of a woman known to be pregnant, regardless of how the drug is labeled. However, it explicitly excludes drugs used to remove a deceased unborn child or treat ectopic pregnancies from this definition.

Severability Clause

There is a severability clause included in the bill, which means if any part of the bill is found to be unconstitutional, the remaining provisions will still stand and remain in effect.

Impact on Enforcement and Liability

The overall goal of the bill is to establish clearer labeling requirements for abortion-inducing drugs, which may enhance accountability and compliance within the relevant healthcare and pharmaceutical sectors.

Relevant Companies

None found.